Stocks · Health care · Pharmaceutical Preparations

Tyra Biosciences, Inc.

TYRA Clue Score32
United States Fiscal year ends December CIK 0001863127 Results filed 4 Aug 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Ra Capital Management, L.p. entity
Director
—
—
—
10,259,291
$211.12M
+37.2%
Robert J More
Director
—
—
—
3,823,425
$78.68M
−6.3%
Todd Harris
President and CEO
—
—
—
1,438,495
$29.60M
+6.1%
Nina S Kjellson
Director
—
—
—
443,885
$9.13M
−20.6%
Daniel Bensen
Chief Discovery Officer
—
—
—
146,981
$3.02M
−65.7%
Alan Fuhrman
Chief Financial Officer
—
—
—
37,115
$763.77K
+188.9%
Gilla Kaplan
Director
—
—
—
28,231
$580.95K
−85.6%
Douglas J Warner
Chief Medical Officer
—
—
—
25,000
$514.46K
—
Bhavesh Ashar
Chief Operating Officer
—
—
—
15,013
$308.94K
—
Yuliya Rueb
Vice President, Finance (PAO)
—
—
—
11,258
$231.67K
—
Rehan Verjee
Director
—
—
—
972
$20.00K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.